In vitro processing of donors' blood with quinine for elimination of malaria parasites

Faculty of Medical Laboratory Sciences, Al Neelain University, PO Box 12702, Khartoum, Sudan.
Saudi medical journal (Impact Factor: 0.59). 08/2006; 27(7):986-91.
Source: PubMed


To eliminate malaria parasites in donors' blood in vitro for eradication of transfusion-induced malaria.
We conducted the study at Ahmed Gasim Hospital in Khartoum, Sudan, between January 2005 and January 2006. Out of 4484 blood samples screened for malaria parasite microscopically, only 30 (200 ml each) satisfied the inclusion criteria of this study. The samples were subdivided equally into 4 portions. Three concentrations of quinine were separately added to 3 specimens while the fourth left without quinine (control). Blood specimens were tested on the day of collection by hematological and biochemical techniques simultaneously, and after 24 and 48 hours at 4-6 degrees celcius by the same techniques.
The number of malaria parasites killed were found to be proportional to the concentrations of quinine and to the storage period, while donors' blood samples without quinine revealed a stable number of the viable parasites during the storage. Quinine was highly effective within 24 hours storage. The detected lethal dose of the applied drug to malaria parasites was generally safe to all constituents of the stored blood.
Our study shows that quinine could be used for the eradication of transfusion-induced malaria by in vitro processing of donors blood. The optimal doses could be added to bags' blood post phlebotomy.

9 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Malaria is a principal cause of mortality in Africa and represents a major blood-borne disease. The studies made on the continent show that transfusion-associated malaria is highly prevalent in blood donors groups and that some risk factors and clinical manifestations are frequently observed. The disease is mostly asymptomatic and the signs are mild, which reduces significantly an efficient selection of the blood donors during the predonation interview and a secure supply of blood products. Furthermore, the lack of appropriate screening assays of the malaria in blood banks on the continent limit the diagnosis of the disease and hamper the blood safety. However, the prevention of transfusion-associated malaria is a frequently asked question. The destruction of the parasite in the blood bag and the recipient anti-malarial prophylaxis are the described possibilities, added to local programs against the vectors of the disease.
    Transfusion Clinique et Biologique 11/2007; 14(5):481-486. DOI:10.1016/j.tracli.2007.12.003 · 0.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The emergence and wide dissemination of drug-resistant malarial parasites underscore the need to prevent post-transfusion malaria. In Nigeria, as in most of sub-Saharan Africa, however, blood donors are not routinely screened for malarial infection. Recently, 391 consecutive potential blood donors in a malaria-endemic area of south-western Nigeria were each checked for malarial parasitaemia using three methods: microscopy (all samples), OptiMAL (315 samples) and/or the Clinotech Malaria Cassette (142 samples). OptiMAL detects parasite-specific lactate dehydrogenase whereas the Clinotech test detects the surface proteins of merozoites and sporozoites. Microscopy revealed parasitaemias in 79 (20.2%) of the potential donors, the levels of parasitaemia varying from 34 to 6289 asexual parasites/microl (mean=445/microl). The prevalence of malarial parasitaemia, as detected by microscopy, was significantly higher during the rainy season than in the dry season (27.3% v. 5.5%; P<0.0001). There was no significant association between patent parasitaemia and fever (i.e. an axillary temperature > or =37.5 degrees C), blood group, gender or anaemia. The corresponding prevalences of malarial parasitaemia detected using the rapid diagnostic tests were 3.8% (12/315) for OptiMAL and 57.8% (82/142) for the Clinotech. With the results of the microscopy used as the 'gold standard', OptiMAL gave a sensitivity of only 16.0% but a specificity of 98.5%. The corresponding values for the Clinotech tests were 69.2% and 50.0%, respectively. It would clearly be beneficial to include screening for malaria parasitaemia in the routine investigation of potential blood donors in Nigeria, especially during the rainy season, when the risk of transfusion-transmitted malaria appears relatively high.
    Pathogens and Global Health 08/2009; 103(5):383-92. DOI:10.1179/136485909X451807 · 1.66 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Prevention of transfusion-transmitted malaria in at-risk children and pregnant women in endemic areas with inexpensive chloroquine is no longer effective due to widespread drug resistance. There is an urgent need for devising new strategies for transfusion malarial safety. We investigated the frequency of transfusion transmission of malaria within the Ghanaian blood donation system using blood donations from 106 asymptomatic adult Ghanaian blood donors. Study Design and Methods Paired samples from 106 blood donations and recipients (before and after transfusion) were tested for anti-merozoite surface protein-1/2 using the commercial Lab21 malaria enzyme immunoassay (EIA), four antigen-specific in-house EIAs, and Plasmodium lactate dehydrogenase (pLDH) EIA. Additionally, Plasmodium DNA was screened for using a species-specific nested polymerase chain reaction (PCR) and a Pan-Plasmodium quantitative PCR. Donor-recipient parasite identity was defined by two concordant genotyping strategies. ResultsPlasmodium antibody prevalence was 100% in both donors and recipients, with at least one antigen. Parasitemia prevalence was 54.7% in both donors and recipients with median levels of 20 and 5.3copies/L, respectively, the difference being correlated to age (p=0.0001). Multiple species infections were frequent (8.5%). Twenty-four units of parasitemic blood were transfused to nonparasitemic recipients, of which 10 (41.7%) became infected after transfusion. Molecular genotyping with 13 distinct markers (antigenic genes and microsatellite loci) identified three to nine parasitemic recipients after transfusion with level of allelic identity suggesting 14% to 28% definite or possible transfusion-related parasitemia. Conclusion None of the currently available screening assays appear suitable to minimize transfusion malaria without compromising the blood supply in endemic areas.
    Transfusion 11/2012; 53(7). DOI:10.1111/j.1537-2995.2012.03943.x · 3.23 Impact Factor


9 Reads
Available from